At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 22 enrolled
Drug / intervention
Capsaicin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Double-Blinded Randomized Prospective Trial of Intranasal Capsaicin Treatment for Non-Allergic Irritant Rhinitis
The University of Texas Health Science Center, Houston·interventional·Posted Jul 9, 2015·Updated Aug 17, 2020
In Brief
A Phase 2 clinical trial evaluating Capsaicin and Placebo for Nonallergic Irritant Rhinitis. Completed, enrolled 22 participants across 1 site.
Detailed Summary
The proposed study seeks to investigate the effect of intranasal capsaicin treatment in patient with Non-allergic irritant rhinitis (NAIR), as well as evaluate optical rhinometry (ORM) as a means to quantify symptomatic improvement in NAIR patients during and after treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNonallergic Irritant Rhinitis
CountriesUnited States
CollaboratorsAmerican Academy of Otolaryngic Allergy
Timeline
Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartOct 2014
First PostedJul 2015
Primary CompletionAug 2019
TodayJul 2026
First PostedJul 9, 2015
Enrollment StartOct 1, 2014
Primary CompletionAug 2, 2019
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 11.0 years ago
Interventions
Capsaicindrug
Placebodrug